Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    19661785 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Cholestasis Reversal: Efficacy of IV Fish Oil
Conditions: Parenteral Nutrition Associated Liver Disease;   Short Bowel Syndrome;   Gastrointestinal Disease
Intervention: Drug: Omegaven®
2 Recruiting Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Condition: Total Parenteral Nutrition-induced Cholestasis
Intervention: Drug: Omegaven®
3 Unknown  Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
Conditions: Short Bowel Syndrome;   Cholestasis
Intervention: Drug: Omegaven Therapy
4 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven

Indicates status has not been verified in more than two years